Hemab Therapeutics Holdings Inc. (COAG) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

Hemab Therapeutics Holdings Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 08/14/2026 7.81 M $286.81 M   100.00% 25.93%
NOVO HOLDINGS A/S 08/14/2026 4.18 M $153.55 M   100.00% 13.88%
FMR LLC 08/13/2026 3.70 M $135.82 M   100.00% 12.28%
CAPITAL INTERNATIONAL INVESTORS 08/12/2026 3.60 M $132.37 M   100.00% 11.97%
DEEP TRACK CAPITAL, LP 08/14/2026 3.60 M $132.30 M   100.00% 11.96%
SIREN, L.L.C. 08/13/2026 2.09 M $76.65 M   100.00% 6.93%
AVORO CAPITAL ADVISORS LLC 08/14/2026 1.93 M $70.71 M   100.00% 6.39%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 08/14/2026 1.65 M $60.60 M   100.00% 5.48%
JPMORGAN CHASE & CO 08/12/2026 1.15 M $42.33 M   100.00% 3.83%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 780.76 K $28.68 M   100.00% 2.59%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 746.04 K $27.40 M   100.00% 2.48%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 715.79 K $26.29 M   100.00% 2.38%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 575.43 K $21.14 M   100.00% 1.91%
BELLEVUE GROUP AG 08/14/2026 550.00 K $20.20 M   100.00% 1.83%
CITADEL ADVISORS LLC 09/02/2026 523.45 K $19.23 M   100.00% 1.74%
BLACKROCK, INC. 08/07/2026 283.83 K $10.43 M   100.00% 0.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 08/14/2026 275.00 K $10.10 M   100.00% 0.91%
EXODUSPOINT CAPITAL MANAGEMENT, LP 08/14/2026 218.29 K $8.02 M   100.00% 0.72%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 211.80 K $7.78 M   100.00% 0.70%
BRAIDWELL LP 08/14/2026 160.00 K $5.88 M   100.00% 0.53%
MARSHALL WACE, LLP 08/13/2026 154.67 K $5.68 M   100.00% 0.51%
WOODLINE PARTNERS LP 08/14/2026 150.04 K $5.51 M   100.00% 0.50%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 138.03 K $5.07 M   100.00% 0.46%
ENSIGN PEAK ADVISORS, INC 08/14/2026 115.39 K $4.24 M   100.00% 0.38%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 112.50 K $4.13 M   100.00% 0.37%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 108.24 K $3.98 M   100.00% 0.36%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 108.24 K $3.98 M   100.00% 0.36%
AMERIPRISE FINANCIAL INC 08/14/2026 81.93 K $3.01 M   100.00% 0.27%
BURKEHILL GLOBAL MANAGEMENT, LP 08/14/2026 75.00 K $2.75 M   100.00% 0.25%
ABRDN PLC 07/31/2026 52.12 K $1.91 M   100.00% 0.17%
OPALEYE MANAGEMENT INC. 08/14/2026 47.65 K $1.75 M   100.00% 0.16%
UBS GROUP AG 08/13/2026 47.35 K $1.74 M   100.00% 0.16%
PARKMAN HEALTHCARE PARTNERS LLC 08/14/2026 45.00 K $1.65 M   100.00% 0.15%
NORTHERN TRUST CORP 08/13/2026 40.49 K $1.49 M   100.00% 0.13%
GHISALLO CAPITAL MANAGEMENT LLC 08/14/2026 40.00 K $1.47 M   100.00% 0.13%
TD ASSET MANAGEMENT INC 08/04/2026 33.10 K $1.22 M   100.00% 0.11%
SEVEN GRAND MANAGERS, LLC 08/14/2026 30.00 K $1.10 M   100.00% 0.10%
SOROS FUND MANAGEMENT LLC 08/14/2026 25.00 K $918.25 K   100.00% 0.08%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 09/09/2026 18.72 K $687.59 K   100.00% 0.06%
GSA CAPITAL PARTNERS LLP 08/06/2026 17.66 K $649.00 K   100.00% 0.06%
XTX TOPCO LTD 08/14/2026 17.39 K $638.70 K   100.00% 0.06%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 08/12/2026 13.18 K $484.21 K   100.00% 0.04%
HUDSON BAY CAPITAL MANAGEMENT LP 08/14/2026 12.20 K $448.18 K   100.00% 0.04%
SCHONFELD STRATEGIC ADVISORS LLC 08/14/2026 10.81 K $397.16 K   100.00% 0.04%
WEISS ASSET MANAGEMENT LP 08/14/2026 10.00 K $367.30 K   100.00% 0.03%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 8.17 K $300.05 K   100.00% 0.03%
VANGUARD GLOBAL ADVISERS, LLC 08/13/2026 7.62 K $279.74 K   100.00% 0.03%
SQUAREPOINT OPS LLC 08/14/2026 6.25 K $229.64 K   100.00% 0.02%
TWO SIGMA INVESTMENTS, LP 08/14/2026 5.68 K $208.63 K   100.00% 0.02%
MORGAN STANLEY 08/13/2026 4.08 K $149.79 K   100.00% 0.01%

Hemab Therapeutics Holdings Inc. institutional Ownership - FAQ's

During the previous two years, 56 institutional investors and hedge funds held shares of Hemab Therapeutics Holdings Inc.. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 7.81 M

Novo Holdings A/S: 4.18 M

FMR LLC: 3.7 M

Capital International Investors: 3.6 M

Deep Track Capital, LP: 3.6 M

Siren, L.L.C.: 2.09 M

120.52% of Hemab Therapeutics Holdings Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 36.29 M shares in the last 24 months. This purchase volume represents approximately $0 in transactions.